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Abstract
Candida osteoarticular infections are being reported with increasing frequency, possibly due to an expanding
population at risk. However, Candida costochondritis is uncommon. We report two cases of Candida
costochondritis in patients who presented with subacute-onset chest wall swelling and whose only identifiable
risk factor was a history of recent intravenous drug use.
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Case Report
Candida costochondritis associated with recent intravenous drug use
Simeon J. Crawford a,*, Christopher D. Swan a, Craig S. Boutlis a,b, Alistair B. Reid a,b
a Department of Infectious Diseases, Wollongong Hospital, Crown Street, Wollongong, NSW 2500, Australia
b Graduate School of Medicine, University of Wollongong, Wollongong, NSW 2500, Australia
Introduction
Candida species commonly colonize the gut and skin of humans
but are also capable of causing significant infections in susceptible
hosts [1]. Osteoarticular infection is a serious and increasingly
reported form of invasive candidiasis [2,3]. However, Candida
costochondritis, once commonly described in injecting drug users
with disseminated candidiasis, has rarely been reported in the last
two decades. Two cases of Candida costochondritis in patients who
had recently injected heroin are reported herein and serve as a
reminder that this remains a clinically relevant infection.
Case reports
Patient 1
A 35-year-old male presented with a one-month history of
painful chest wall swelling, subjective fever, anorexia and
unintended weight loss. He had a history intravenous drug use
(IVDU), last injecting heroin 2 months earlier. On examination,
there was a firm, smooth 5 cm  10 cm swelling over the right
lower ribs anteriorly. The lesion was tender to palpation and fixed
to underlying structures; overlying skin was indurated and mildly
erythematous. A firm, tender lymph node was palpable in the right
axilla. Laboratory findings included normocytic anemia (hemoglo-
bin 11.7 g/dL; normal range 13.0–18.0 g/dL), mildly elevated C-
reactive protein (CRP) concentration (27 mg/L; normal range
<5 mg/L) and erythrocyte sedimentation rate (ESR) (32 mm/h;
normal range 0–14 mm/h). Hepatitis C virus antibody was
positive; human immunodeficiency virus antigen/antibody test
was negative. There was no growth from three sets of blood
cultures. Chest computed tomography (CT) demonstrated a soft
tissue mass arising from the right seventh costochondral junction
with erosion of the costal cartilage and communication with a
5.0 cm  1.3 cm fluid collection superficial to the liver (Fig. 1).
While awaiting percutaneous biopsy, the mass became fluctu-
ant and discharged thick purulent material. An aspirate, immedi-
ately obtained for microscopy and culture, demonstrated pus cells
and scanty growth of Candida albicans. Surgical debridement was
performed and C. albicans was cultured from intra-operative
specimens; susceptibility of the isolate to fluconazole was
assumed due to very low rates of fluconazole resistance among
C. albicans isolates in our region. Histopathological examination of
the specimen demonstrated suppurative, noncaseating, granulo-
matous inflammation with no organisms seen on routine or special
stains. The patient commenced fluconazole 400 mg orally daily for
Candida costochondritis. Within three months, the chest wall
swelling had resolved and he had gained weight. Antifungal
therapy was ceased after 6 months and the patient has remained
asymptomatic in follow up for over 6 months.
Patient 2
A 49-year-old female presented with a two-month history of
two painful chest wall swellings, lethargy and anorexia. There was
no documented fever or weight loss. Her medical history was
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notable for IVDU and hepatitis C virus infection with spontaneous
clearance. She last injected heroin 4 months earlier. On examina-
tion, she exhibited firm, tender chest wall swellings over the left
lower parasternal region and the right eighth rib anteriorly.
Overlying skin was indurated but not erythematous. There was no
palpable lymphadenopathy. Serum CRP concentration and ESR
were elevated at 28.5 mg/L and 32 mm/h respectively. Chest CT
demonstrated two heterogeneous masses, one over the left
seventh costal cartilage, adjacent to the xiphisternum, measuring
3.5 cm in greatest diameter and one arising from the right eighth
costochondral junction measuring 4.5 cm; there was cartilaginous
erosion associated with the latter.
Percutaneous biopsy of the right-sided lesion was performed
and culture of the specimen produced scanty growth of C. albicans.
There was no growth from blood cultures and no features of
infective endocarditis on transthoracic echocardiography. The
patient commenced fluconazole 400 mg orally daily. Due to
limited response after 1 month, surgical resection of both chest
wall lesions was performed. Histopathological examination of the
surgical specimens demonstrated a mixed inflammatory infiltrate
but no granulomas. The specimens were received in formalin and
could not be cultured. Surgical resection was followed by rapid
resolution of symptoms. The patient completed 6 months of
fluconazole without incident and remains well over 6 months after
ceasing therapy.
Discussion
Candida osteoarticular infection is a serious form of invasive
candidiasis associated with significant morbidity. Most infections
arise from hematogenous seeding during candidemia, with the
remainder due to direct inoculation or contiguous spread
following trauma or surgery [1–3]. Reports of Candida osteoarti-
cular infection may reflect rising prevalence of risk factors
associated with candidemia: two recent literature reviews
reported high rates of major surgery, broad-spectrum antimicro-
bial use, immunosuppression, central venous access devices,
parenteral nutrition, and IVDU among patients with Candida
osteomyelitis [2,3].
The earliest reported cases of Candida costochondritis occurred
following thoracic surgery [4], with the first IVDU-associated
report published in 1981.[5] Collignon subsequently described a
distinctive syndrome of eye lesions, skin lesions, osteomyelitis, and
costochondritis due to C. albicans in patients who had recently
injected heroin [6]; later studies implicated Candida-contaminated
lemon juice used to dissolve brown heroin (a base that is poorly
water-soluble) [7]. Outbreaks of invasive candidiasis among
injecting drug users in Europe in the 1980s were notable for high
rates of costochondritis [8], but there have been few reports of
Candida costochondritis since, possibly reflecting changes in drug
availability and injecting practices.
The clinical and diagnostic features of Candida costochon-
dritis have been described only in small series [8–10]. Patients
present with insidious onset of a mildly painful chest wall
swelling. The mass is usually firm, but longstanding lesions may
become fluctuant or discharge. Constitutional symptoms are
variable but fever >38 8C is rarely recorded. Candida infection at
other sites is common, necessitating thorough physical assess-
ment; skin, eyes, bones and joints are the most frequently
affected sites. Markers of inflammation such as leukocyte count,
CRP concentration and ESR are usually modestly elevated.
Multiple blood cultures should be performed to exclude
candidemia, but Candida is infrequently cultured from the
blood at the time of diagnosis. The role of echocardiography is
uncertain unless candidemia is proven. CT of the chest with
intravenous contrast may show a mass arising from the
costochondral junction, erosion of the adjacent cartilage or
rib, invasion of the surrounding soft tissues or formation of a
sinus. Imaging also helps differentiate infection from other
causes of chest wall swelling such as tumors. Percutaneous or
open biopsy is the diagnostic test of choice with specimens
submitted for histopathology as well as routine bacterial, fungal
and mycobacterial stains and cultures. Histopathological exam-
ination of biopsied tissue may demonstrate mixed inflammatory
cell infiltrate, noncaseating granulomas and fungal elements. C.
albicans is the species most commonly identified in culture [8–
10].
Prolonged antifungal therapy is the mainstay of treatment for
Candida costochondritis. The choice of agent, route of administra-
tion and duration are determined by antimicrobial sensitivity, the
severity of infection and potential toxicity. Adjunctive surgical
debridement or resection is frequently required to achieve cure
[11].
Candida costochondritis, once a commonly reported manifes-
tation of disseminated candidiasis in intravenous drug users, has
rarely been reported in the last 20 years. We report two cases of
Candida costochondritis that highlight the typical presentation
of this infection and serve as a reminder of its ongoing clinical
relevance. The presumed mechanism of infection in our patients
was hematogenous seeding following self-injection of Candida-
contaminated narcotics. For reasons that are unclear, injecting
drug users seem to be at increased risk of developing
costochondritis following candidemia and clinicians should
be aware of this as a potential presentation. Surgical debride-
ment and prolonged antifungal therapy leads to favorable
outcomes.
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Fig. 1. Chest computed tomography of Patient 1, showing a soft tissue mass arising
from the right seventh costochondral junction with erosion of the costal cartilage
and communication with an extra-capsular perihepatic fluid collection.
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